Moderate-to-severe Asthma research hub
3 indexed studies · 2 currently recruiting
- recruitingTherapeutic exploratory (Phase II)
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma
This study is testing a new medicine called rocatinlimab for adults with moderate-to-severe asthma. Researchers want to find the best dose and see if it cuts down asthma attacks that need steroid tablets or hospital care, while checking how safe and effective it is compared with a dummy medicine.
Romania · Czechia · Hungary - recruitingHuman Pharmacology (Phase I)- Other
A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Selnoflast in Participants with Moderate to Severe Asthma
This study is testing a new medicine, Selnoflast, for people with moderate to severe asthma. Researchers want to see if it's safe, how it moves through the body, and what effects it has. It's an early-stage study, open to adults aged 18 and over.
Belgium · Netherlands · Germany - completedPhase III
Seasonal asthma exacerbation prevention with depemokimab
This study is testing a new medicine called depemokimab to see if it can prevent asthma attacks during autumn and winter. It's for adults with moderate-to-severe asthma and will compare the new medicine to a dummy treatment.
United Kingdom